Document Detail


Safety and effectiveness outcomes of an inpatient collaborative drug therapy management service for direct thrombin inhibitors.
MedLine Citation:
PMID:  23135566     Owner:  NLM     Status:  In-Data-Review    
Abstract/OtherAbstract:
Purpose The impact of a collaborative drug therapy management (CDTM) agreement enabling pharmacist-managed direct thrombin inhibitor (DTI) therapy was evaluated. Methods A retrospective chart review was conducted to compare selected outcome measures between cohorts of adults who received argatroban or bivalirudin therapy for suspected heparin-induced thrombocytopenia (HIT) before (n = 25) and after (n = 25) the implementation of an institutional DTI protocol under which properly trained and credentialed pharmacists have a primary role in dosing and monitoring DTI infusions. The primary endpoints were the mean time to attainment of activated partial thromboplastin time (aPTT) values in a specified therapeutic range and the proportion of total inpatient treatment time during which aPTT values were in that range. Secondary endpoints included the incidence of major and minor bleeding and the incidence of medication errors. Results After implementation of the DTI protocol, therapeutic aPTT values were achieved more rapidly (a mean of 3.4 hours in the postimplementation cohort versus a mean of 7.7 hours in the preimplementation cohort, p = 0.009) and maintained more consistently. Rates of bleeding and overall mortality were similar in the two groups; the frequencies of documented medication errors were 12% and 40% in the postimplementation and preimplementation cohorts, respectively (p = 0.05). Conclusion A pharmacist-driven DTI program resulted in improved effectiveness and safety outcomes, as demonstrated by improved attainment of target aPTT values and a decreased frequency of medication errors. Am J Health-Syst Pharm. 2012; 69:1993-8.
Authors:
Tanna Cooper; Carol L White; David Taber; Walter E Uber; Heather Kokko; Joseph Mazur
Related Documents :
11364956 - Security guard at smithsonian not protected by rehab act.
10184476 - Commissioner v. schleier: back to the drawing board on the taxation of employment dispu...
19986206 - President's address: psychiatry and the report of the royal commission.
8463416 - Certifying the cause of death: an audit of wording inaccuracies.
23203046 - Bacterial exopolysaccharides: functionality and prospects.
8002686 - Comparison of patients' compliance with prescribed oral and inhaled asthma medications.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists     Volume:  69     ISSN:  1535-2900     ISO Abbreviation:  Am J Health Syst Pharm     Publication Date:  2012 Nov 
Date Detail:
Created Date:  2012-11-08     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9503023     Medline TA:  Am J Health Syst Pharm     Country:  United States    
Other Details:
Languages:  eng     Pagination:  1993-8     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Survey of Alberta hospital pharmacists' perspectives on additional prescribing authorization.
Next Document:  Extended stability of intravenous acetaminophen in syringes and opened vials.